Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Brain Disorders

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Brain Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hagspiel, KD; Hermes, M; Kujat, C; Neidl, KF; Voges, M1
Angelberger, P; Brücke, T; Deecke, L; Küfferle, B; Müller, C; Podreka, I; Topitz, A; Wenger, S1

Reviews

1 review(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Brain Disorders

ArticleYear
[Single photon emission tomography (SPECT). Cerebral function diagnosis for the clinical routine. Indications and radiotracers].
    Der Radiologe, 1993, Volume: 33, Issue:11

    Topics: Benzamides; Brain Diseases; Flumazenil; Humans; Iodine Radioisotopes; Organotechnetium Compounds; Oximes; Pyrrolidines; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon

1993

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Brain Disorders

ArticleYear
Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1991, Volume: 11, Issue:2

    Topics: Adult; Aged; Aging; Antipsychotic Agents; Benzamides; Brain Diseases; Cerebellum; Corpus Striatum; Frontal Lobe; Humans; Huntington Disease; Iodine Radioisotopes; Levodopa; Middle Aged; Parkinson Disease; Pyrrolidines; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Tissue Distribution; Tomography, Emission-Computed, Single-Photon

1991